BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
229 hedge funds and large institutions have $1.59B invested in bluebird bio in 2021 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 64 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
229
Holders Change
-33
Holders Change %
-12.6%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
48
Increased
85
Reduced
64
Closed
78
Calls
$25.8M
Puts
$45.8M
Net Calls
-$20M
Net Calls Change
-$16.8M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$209M |
| 2 |
AC
Armistice Capital
New York
|
$59.2M |
| 3 |
SCM
Suvretta Capital Management
New York
|
$39.3M |
| 4 |
SC
Sessa Capital
New York
|
$26.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
$70M |
